Filana Therapeutics (FLNA) Payables (2010 - 2024)
Filana Therapeutics (FLNA) posted quarterly Payables of $65.4 million for Q1 2024, up 693.11% year-over-year from $8.2 million in Q2 2023, and up 532.31% quarter-over-quarter from $10.3 million in Q2 2023.
Filana Therapeutics (FLNA) Payables (2010 - 2024) Analysis & Trends
Filana Therapeutics' Payables history runs 15 years deep, the most recent figure standing at $65.4 million for Q1 2024.
- In Q1 2024, Payables rose 693.11% year-over-year to $65.4 million; the TTM figure through Mar 2024 stood at $65.4 million (up 693.11% YoY), while the FY2022 annual figure was $4.0 million, down 43.63% from the prior year.
- Payables for Q1 2024 stood at $65.4 million, up from $10.3 million in the prior quarter.
- The five-year high for Payables was $65.4 million in Q1 2024, with the low at $416000.0 in Q2 2020.
- The 5-year median for Payables is $3.3 million (2022), against an average of $7.6 million.
- The sharpest annual moves came in 2022 and 2024: Payables plunged 43.63% in 2022, then jumped 693.11% in 2024.
- Filana Therapeutics' Payables stood at $911000.0 in 2020, then jumped by 682.22% to $7.1 million in 2021, then sank by 43.63% to $4.0 million in 2022, then surged by 157.36% to $10.3 million in 2023, then jumped by 532.31% to $65.4 million in 2024.
- Business Quant data shows FLNA's Payables at $65.4 million in Q1 2024, $10.3 million in Q2 2023, and $8.2 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Filana Therapeutics | 46.00 Mn | 46.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 65.37 Mn |
| Jun 30, 2023 | 10.34 Mn |
| Mar 31, 2023 | 8.24 Mn |
| Dec 31, 2022 | 4.02 Mn |
| Sep 30, 2022 | 3.53 Mn |
| Jun 30, 2022 | 4.76 Mn |
| Mar 31, 2022 | 3.33 Mn |
| Dec 31, 2021 | 7.13 Mn |
| Sep 30, 2021 | 2.35 Mn |
| Jun 30, 2021 | 1.91 Mn |
| Mar 31, 2021 | 864,000.00 |
| Dec 31, 2020 | 911,000.00 |
| Sep 30, 2020 | 465,000.00 |
| Jun 30, 2020 | 416,000.00 |
| Mar 31, 2020 | 608,000.00 |
| Dec 31, 2019 | 453,000.00 |
| Sep 30, 2019 | 340,000.00 |
| Jun 30, 2019 | 594,000.00 |
| Mar 31, 2019 | 495,000.00 |
| Dec 31, 2018 | 294,000.00 |